# Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation

Study · id `cardio:ct-nct01851525` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01851525](<https://clinicaltrials.gov/study/NCT01851525>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01851525

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It plans to enroll 120 participants.

## Technical summary

Registry record NCT01851525. Randomized; no masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2017-02-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT01851525, source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)
- Start date: 2013-06 (registry gives no type) (ClinicalTrials.gov record NCT01851525, source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)
- Primary completion: 2017-02-15 (actual) (ClinicalTrials.gov record NCT01851525, source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)
- Completion: 2017-02-15 (actual) (ClinicalTrials.gov record NCT01851525, source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT01851525, source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01851525-2017-04-25`, retrieved 2026-10-26)

## The registry's words

- Brief title: Therapeutic Outcomes Using Contact Force Handling During Atrial Fibrillation Ablation
- Acronym: TOUCH AF
- Condition: Persistent Atrial Fibrillation
- Intervention (Device): ThermoCoolSmartTouch ablation catheter, Biosense Webster
- Lead sponsor: Southlake Health
- Lead sponsor class: OTHER
- Collaborator: Applied Health Research Centre
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: Southlake Health (`cardio:org-southlake-health`)
- Registry lists this organization as a collaborator: Applied Health Research Centre (`cardio:org-applied-health-research-centre`)

## Provenance

Content hash: f3370e6e2fcaa773634aa6a6da603e7f67fe9274e6b709bbf5db4f1c5c96d12b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
